Don Weissman, MD

Life Sciences and Healthcare


Medical & Regulatory Affairs
 KOL Relationships and Governance

Senior Medical Science Liaison

 

  Initiatives, Alliances, Partnerships

Strategic Business Development
 Education and Insights 

Applications, Adoption, Advocacy 

  Better Healthcare Better Outcomes



 

                                                       

 

 

"A MISSION OF BETTER HEALTH and QUALITY OF LIFE"


Entrepreneurial Executive Physician
S
enior Medical Science Liaison

Business Development Specialist

 Medical Affairs and KOL Governance

  Strategic Product and Market Development

   Bio-Pharmaceuticals, Technologies, Devices 


 

Outstanding KOL, HCP and C level relationships 

development across the Healthcare & Life Science spectrum. 


Proven track record of success helping Life Science Companies 

and Healthcare Institutions accelerate product development,

and optimize market success for patient benefits, 

better outcomes and quality of life for

caretakers, providers and stakeholders. 

 

Exceptional training, presentation, education, 

communication and commercialization skills.


Key Opinion Leader insights and trials, 

applications, analytics and advocacy.


Advisory Board Development, Honored Society

 and Board Relationships 

 best Academic & University Medical Centers,
Physicians of Influence, 
Hospitals and Institutions. 

  

Analyst and panel review member for the National Science Foundation,
the National Institute of Health and the Department of Health and

Human Services: biomedical research, diagnostics, genomics
bio-pharmaceuticals, devices and innovative therapeutics.


Adept listener, articulate and persuasive, 
building professional consensus for approvals and advocacy,
patient compliance and adherence, understanding
needs, drivers and implementations for success. 
 
In-depth Medical and Regulatory affairs, 
pharmaco-economics and vigilance for resource
allocation and guidelines. Highly successful with the FDA, FTC,
PhRMA, AHRQ and CMS. Proven track record of success for coverage
and reimbursements by all providers, payers and plans.
 
 

Honored society, academic and board relationships for strategic CME,
regional and national symposium, peer review publications, brand
and market development, mobile and social media
applications with validation. 

 

Extraordinary resources, knowledge & relationships, training and motivational

 skills building and strengthening internal and external relationships, 

partnerships and collaborative team work with renowned academic, 

research, government and clinical leaderships.

 

GOALS:

 

                

Innovative therapeutics, diagnostics and services

to treat, ameliorate, cure and prevent.


 

To optimize patient well being and quality of life
 excellence
in clinical, operational and financial outcomes.